期刊
HPB
卷 13, 期 11, 页码 783-791出版社
ELSEVIER SCI LTD
DOI: 10.1111/j.1477-2574.2011.00355.x
关键词
hepatocellular carcinoma < liver; outcomes < transplant; resection < liver; radiological intervention - CT/US guided < liver
Objective: The optimal strategy for treating hepatocellular carcinoma (HCC), a disease with increasing incidence, in patients with Child-Pugh class A cirrhosis has long been debated. This study evaluated the cost-effectiveness of hepatic resection (HR) or locoregional therapy (LRT) followed by salvage orthotopic liver transplantation (SOLT) vs. that of primary orthotopic liver transplantation (POLT) for HCC within the Milan Criteria. Methods: A Markov-based decision analytic model simulated outcomes, expressed in costs and quality-adjusted life years (QALYs), for the three treatment strategies. Baseline parameters were determined from a literature review. Sensitivity analyses tested model strength and parameter variability. Results: Both HR and LRT followed by SOLT were associated with earlier recurrence, decreased survival, increased costs and decreased quality of life (QoL), whereas POLT resulted in decreased recurrence, increased survival, decreased costs and increased QoL. Specifically, HR/SOLT yielded 3.1 QALYs (at US$ 96 000/QALY) and LRT/SOLT yielded 3.9 QALYs (at US$ 74 000/QALY), whereas POLT yielded 5.5 QALYs (at US$ 52 000/QALY). Sensitivity analyses supported these findings at clinically meaningful probabilities. Conclusions: Under the Model for End-stage Liver Disease (MELD) system, in patients with HCC within the Milan Criteria, POLT increases survival and QoL at decreased costs compared with HR or LRT followed by SOLT. Therefore, POLT is the most cost-effective strategy for the treatment of HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据